Please use this identifier to cite or link to this item:
|Title:||Toxicogenetic profile and cancer risk in Lebanese||Authors:||Dhaini, Hassan
Kobeissi, Loulou H
|Affiliations:||Department of Medical Laboratory Sciences||Issue Date:||2014||Part of:||Journal of toxicol environ health part B critical reviews||Volume:||17||Issue:||2||Start page:||95||End page:||125||Abstract:||
An increasing number of genetic polymorphisms in drug-metabolizing enzymes (DME) were identified among different ethnic groups. Some of these polymorphisms are associated with an increased cancer risk, while others remain equivocal. However, there is sufficient evidence that these associations become significant in populations overexposed to environmental carcinogens. Hence, genetic differences in expression activity of both Phase I and Phase II enzymes may affect cancer risk in exposed populations. In Lebanon, there has been a marked rise in reported cancer incidence since the 1990s. There are also indicators of exposure to unusually high levels of environmental pollutants and carcinogens in the country. This review considers this high cancer incidence by exploring a potential gene-environment model based on available DME polymorphism prevalence, and their impact on bladder, colorectal, prostate, breast, and lung cancer in the Lebanese population. The examined DME include glutathione S-transferases (GST), N-acetyltransferases (NAT), and cytochromes P-450 (CYP). Data suggest that these DME influence bladder cancer risk in the Lebanese population. Evidence indicates that identification of a gene-environment interaction model may help in defining future research priorities and preventive cancer control strategies in this country, particularly for breast and lung cancer.
|Appears in Collections:||Department of Medical Laboratory Sciences|
Show full item record
checked on Oct 25, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.